RemedyRepack Inc. recalls Metformin 750 mg Extended Release NDC # 70518-2920-00
Recalled January 19, 2022 · FDA recall D-0366-2022 · RemedyRepack
Hazard
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit. · FDA Class II
Units
56 Blister Cards
Sold at
Product was distributed to one direct account in PA.
Description
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Product
Metformin 750 mg Extended Release NDC # 70518-2920-00
Manufacturer(s)
RemedyRepack Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →